Viewing Study NCT01243359


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2025-12-27 @ 1:12 PM
Study NCT ID: NCT01243359
Status: COMPLETED
Last Update Posted: 2014-04-02
First Post: 2010-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module